FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956286257> ?p ?o ?g. }

• W2956286257 endingPage "6147" @default.
• W2956286257 startingPage "6141" @default.
• W2956286257 abstract "Abstract Purpose: Recent sequencing studies revealed that a subset of colorectal cancer harbors a significantly higher number of somatic mutations. These hypermutated tumors show distinct clinicopathologic features. However, the prognostic impact of the hypermutated tumors is not clearly established. Experimental Design: We analyzed tumor mutation burden (TMB) from targeted next-generation sequencing data of 40 major genes in 516 patients with colorectal cancer. TMB was defined as total number of nonsynonymous mutations per tumor. Cutoff value for TMB-high was chosen by which best discriminated relapse-free survival (RFS) using the Contal and O'Quigley method. Results: In the TCGA data, mutation count of the selected 40 genes reflected the whole exome mutation burden (Pearson correlation = 0.873, P &lt; 0.001). In our patient cohort, 8 or more mutations in the 40 genes was defined as TMB-high, which best discriminated RFS. A total of 55 patients (10.7%) had TMB-high. TMB-high tumors were more frequently found in a proximal location (63.6%) and had a higher proportion of N0 disease (30.9%) and MSI-H (49.1%) compared with TMB-low. Most importantly, TMB-high was associated with better 5-year RFS compared with TMB-low (96.3% vs. 79.8%, P = 0.005). Although there was significant overlap between TMB-high and MSI-H, MSI-H status was not significantly associated with RFS. Multivariate analysis revealed TMB-high as an independent positive prognostic factor for RFS [adjusted HR, 0.16 (95% confidence interval, 0.04–0.66), P = 0.011]. Conclusions: TMB-high is associated with better prognosis in patients with colorectal cancer treated with curative surgery followed by adjuvant fluoropyrimidine and oxaliplatin chemotherapy." @default.
• W2956286257 created "2019-07-23" @default.
• W2956286257 creator A5016851125 @default.
• W2956286257 creator A5019220210 @default.
• W2956286257 creator A5021701020 @default.
• W2956286257 creator A5027006773 @default.
• W2956286257 creator A5047219538 @default.
• W2956286257 creator A5048050478 @default.
• W2956286257 creator A5056013655 @default.
• W2956286257 creator A5072199311 @default.
• W2956286257 creator A5076087101 @default.
• W2956286257 creator A5088893123 @default.
• W2956286257 creator A5091289899 @default.
• W2956286257 date "2019-10-15" @default.
• W2956286257 modified "2023-10-11" @default.
• W2956286257 title "Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin" @default.
• W2956286257 cites W1940241680 @default.
• W2956286257 cites W1971870484 @default.
• W2956286257 cites W1984642649 @default.
• W2956286257 cites W1985532701 @default.
• W2956286257 cites W1993928295 @default.
• W2956286257 cites W2009719437 @default.
• W2956286257 cites W2011143480 @default.
• W2956286257 cites W2042797183 @default.
• W2956286257 cites W2050658928 @default.
• W2956286257 cites W2108375386 @default.
• W2956286257 cites W2123636561 @default.
• W2956286257 cites W2132105937 @default.
• W2956286257 cites W2140143664 @default.
• W2956286257 cites W2144495943 @default.
• W2956286257 cites W2147698761 @default.
• W2956286257 cites W2170137783 @default.
• W2956286257 cites W2262414037 @default.
• W2956286257 cites W2605738899 @default.
• W2956286257 cites W2616843759 @default.
• W2956286257 cites W2622499649 @default.
• W2956286257 cites W2747774814 @default.
• W2956286257 cites W2767034994 @default.
• W2956286257 cites W2797675588 @default.
• W2956286257 cites W2811502909 @default.
• W2956286257 cites W2921349646 @default.
• W2956286257 doi "https://doi.org/10.1158/1078-0432.ccr-19-1105" @default.
• W2956286257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31285374" @default.
• W2956286257 hasPublicationYear "2019" @default.
• W2956286257 type Work @default.
• W2956286257 sameAs 2956286257 @default.
• W2956286257 citedByCount "83" @default.
• W2956286257 countsByYear W29562862572020 @default.
• W2956286257 countsByYear W29562862572021 @default.
• W2956286257 countsByYear W29562862572022 @default.
• W2956286257 countsByYear W29562862572023 @default.
• W2956286257 crossrefType "journal-article" @default.
• W2956286257 hasAuthorship W2956286257A5016851125 @default.
• W2956286257 hasAuthorship W2956286257A5019220210 @default.
• W2956286257 hasAuthorship W2956286257A5021701020 @default.
• W2956286257 hasAuthorship W2956286257A5027006773 @default.
• W2956286257 hasAuthorship W2956286257A5047219538 @default.
• W2956286257 hasAuthorship W2956286257A5048050478 @default.
• W2956286257 hasAuthorship W2956286257A5056013655 @default.
• W2956286257 hasAuthorship W2956286257A5072199311 @default.
• W2956286257 hasAuthorship W2956286257A5076087101 @default.
• W2956286257 hasAuthorship W2956286257A5088893123 @default.
• W2956286257 hasAuthorship W2956286257A5091289899 @default.
• W2956286257 hasBestOaLocation W29562862571 @default.
• W2956286257 hasConcept C104317684 @default.
• W2956286257 hasConcept C121608353 @default.
• W2956286257 hasConcept C126322002 @default.
• W2956286257 hasConcept C141231307 @default.
• W2956286257 hasConcept C143998085 @default.
• W2956286257 hasConcept C149904235 @default.
• W2956286257 hasConcept C180754005 @default.
• W2956286257 hasConcept C2779767149 @default.
• W2956286257 hasConcept C2780962732 @default.
• W2956286257 hasConcept C2781187634 @default.
• W2956286257 hasConcept C501734568 @default.
• W2956286257 hasConcept C502942594 @default.
• W2956286257 hasConcept C526805850 @default.
• W2956286257 hasConcept C54355233 @default.
• W2956286257 hasConcept C61320498 @default.
• W2956286257 hasConcept C71924100 @default.
• W2956286257 hasConcept C86803240 @default.
• W2956286257 hasConceptScore W2956286257C104317684 @default.
• W2956286257 hasConceptScore W2956286257C121608353 @default.
• W2956286257 hasConceptScore W2956286257C126322002 @default.
• W2956286257 hasConceptScore W2956286257C141231307 @default.
• W2956286257 hasConceptScore W2956286257C143998085 @default.
• W2956286257 hasConceptScore W2956286257C149904235 @default.
• W2956286257 hasConceptScore W2956286257C180754005 @default.
• W2956286257 hasConceptScore W2956286257C2779767149 @default.
• W2956286257 hasConceptScore W2956286257C2780962732 @default.
• W2956286257 hasConceptScore W2956286257C2781187634 @default.
• W2956286257 hasConceptScore W2956286257C501734568 @default.
• W2956286257 hasConceptScore W2956286257C502942594 @default.
• W2956286257 hasConceptScore W2956286257C526805850 @default.
• W2956286257 hasConceptScore W2956286257C54355233 @default.
• W2956286257 hasConceptScore W2956286257C61320498 @default.
• W2956286257 hasConceptScore W2956286257C71924100 @default.
• W2956286257 hasConceptScore W2956286257C86803240 @default.

• next